Lymphatica Medtech
Series B in 2024
Lymphatica Medtech SA is a Swiss company focused on designing and manufacturing medical devices for the treatment of lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed LymphoDrain, an innovative medical device that aims to re-establish lymphatic circulation. This system includes an active implantable lymphatic bypass, featuring a magnetically controlled micropump and subcutaneous catheters that facilitate the internal drainage of lymphatic fluid from multiple points within the affected limb. Lymphatica Medtech also produces essential components for LymphoDrain, such as the micropump head and wearable controller, providing a minimally invasive solution for individuals suffering from persistent lymphedema.
Synthara
Venture Round in 2024
Synthara AG, a Swiss semiconductor startup founded in 2019 and based in Zurich, specializes in designing advanced smart sensors for industrial Internet of Things (IoT) applications and other energy-sensitive uses. The company focuses on developing energy-efficient computational AI chips tailored for various applications, including wearables, health monitoring, augmented reality/virtual reality, and aerospace technologies. Its flagship product, ComputeRAM, serves as a drop-in replacement for traditional SRAM, enabling complex calculations to be performed directly in memory. This innovation significantly reduces CPU workload, enhances system performance, and improves efficiency, particularly for AI applications. Synthara's technology is processor-type agnostic, compatible with architectures such as RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By empowering chipmakers and device manufacturers, Synthara aims to lower costs, accelerate time to market, and foster new avenues for innovation in the semiconductor industry.
Neural Concept
Series B in 2024
Neural Concept Sàrl is a Swiss company founded in 2018 that specializes in artificial intelligence algorithms for computer-assisted engineering and design. Based in Lausanne, it provides a platform that employs 3D deep learning algorithms to enhance the engineering processes for industries such as automotive, additive manufacturing, energy, and naval-aerospace. By automating and accelerating research and development cycles, Neural Concept aids companies in improving product performance while reducing computational costs. With a dedicated team of over 30 members, the company is committed to transforming industrial engineering through innovative technology.
Invasight
Seed Round in 2022
Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.
Neural Concept
Series A in 2022
Neural Concept Sàrl is a Swiss company founded in 2018 that specializes in artificial intelligence algorithms for computer-assisted engineering and design. Based in Lausanne, it provides a platform that employs 3D deep learning algorithms to enhance the engineering processes for industries such as automotive, additive manufacturing, energy, and naval-aerospace. By automating and accelerating research and development cycles, Neural Concept aids companies in improving product performance while reducing computational costs. With a dedicated team of over 30 members, the company is committed to transforming industrial engineering through innovative technology.
Alentis Therapeutics
Series B in 2021
Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapies for advanced liver diseases, including liver fibrosis, cirrhosis, and liver cancer. Established in 2019, Alentis is recognized for its pioneering work in targeting CLDN1+ cancers through the use of anti-CLDN1 antibody-drug conjugates and other therapeutic modalities. The company's research platform incorporates clinically relevant read-outs and single-cell RNA sequencing of patient liver tissues, which aids in understanding and treating fibrotic diseases. Alentis aims to modify and reverse disease progression, ultimately addressing significant health challenges associated with liver-related conditions.
Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.
Neural Concept
Seed Round in 2021
Neural Concept Sàrl is a Swiss company founded in 2018 that specializes in artificial intelligence algorithms for computer-assisted engineering and design. Based in Lausanne, it provides a platform that employs 3D deep learning algorithms to enhance the engineering processes for industries such as automotive, additive manufacturing, energy, and naval-aerospace. By automating and accelerating research and development cycles, Neural Concept aids companies in improving product performance while reducing computational costs. With a dedicated team of over 30 members, the company is committed to transforming industrial engineering through innovative technology.
Gilytics
Seed Round in 2020
Gilytics AG specializes in developing advanced computing and 3D visualization technology solutions aimed at optimizing the planning of transportation and energy infrastructures. Founded in 2017 and based in Zurich, Switzerland, the company offers a software-as-a-service (SaaS) platform that automates the planning and siting of both linear and distributed infrastructure, including energy and transport sectors. Its interactive web application assists various industries, such as utilities, power grid operators, and renewable energy projects, by providing tools for identifying optimal routes for new transmission lines. Additionally, Gilytics enhances stakeholder engagement through its 3D visualization capabilities, facilitating better communication with authorities and communities involved in infrastructure development.
Lymphatica Medtech
Series A in 2020
Lymphatica Medtech SA is a Swiss company focused on designing and manufacturing medical devices for the treatment of lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed LymphoDrain, an innovative medical device that aims to re-establish lymphatic circulation. This system includes an active implantable lymphatic bypass, featuring a magnetically controlled micropump and subcutaneous catheters that facilitate the internal drainage of lymphatic fluid from multiple points within the affected limb. Lymphatica Medtech also produces essential components for LymphoDrain, such as the micropump head and wearable controller, providing a minimally invasive solution for individuals suffering from persistent lymphedema.
Synthara
Seed Round in 2020
Synthara AG, a Swiss semiconductor startup founded in 2019 and based in Zurich, specializes in designing advanced smart sensors for industrial Internet of Things (IoT) applications and other energy-sensitive uses. The company focuses on developing energy-efficient computational AI chips tailored for various applications, including wearables, health monitoring, augmented reality/virtual reality, and aerospace technologies. Its flagship product, ComputeRAM, serves as a drop-in replacement for traditional SRAM, enabling complex calculations to be performed directly in memory. This innovation significantly reduces CPU workload, enhances system performance, and improves efficiency, particularly for AI applications. Synthara's technology is processor-type agnostic, compatible with architectures such as RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By empowering chipmakers and device manufacturers, Synthara aims to lower costs, accelerate time to market, and foster new avenues for innovation in the semiconductor industry.
PXL Vision
Seed Round in 2020
PXL Vision AG, founded in 2017 and headquartered in Zurich, Switzerland, specializes in the design and development of identity verification and customer onboarding software solutions. Its flagship product, Daego, employs advanced computer vision and machine learning technologies to create trusted digital identities. This cross-platform solution is tailored to meet the needs of various industries, including insurance, fintech, and healthcare, by automating the verification of identity documents and performing facial biometric checks to ensure that users are legitimate and the rightful owners of their documents. By facilitating secure and efficient customer onboarding, PXL Vision aims to enhance conversion rates, reduce costs associated with compliance, and mitigate identity fraud. With research and development centers in Novi Sad, Serbia, and Yerevan, Armenia, PXL Vision is dedicated to establishing a foundation of trust in digital interactions through unbiased and verifiable identities.
Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.
Neural Concept
Venture Round in 2019
Neural Concept Sàrl is a Swiss company founded in 2018 that specializes in artificial intelligence algorithms for computer-assisted engineering and design. Based in Lausanne, it provides a platform that employs 3D deep learning algorithms to enhance the engineering processes for industries such as automotive, additive manufacturing, energy, and naval-aerospace. By automating and accelerating research and development cycles, Neural Concept aids companies in improving product performance while reducing computational costs. With a dedicated team of over 30 members, the company is committed to transforming industrial engineering through innovative technology.
Alentis Therapeutics
Series A in 2019
Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapies for advanced liver diseases, including liver fibrosis, cirrhosis, and liver cancer. Established in 2019, Alentis is recognized for its pioneering work in targeting CLDN1+ cancers through the use of anti-CLDN1 antibody-drug conjugates and other therapeutic modalities. The company's research platform incorporates clinically relevant read-outs and single-cell RNA sequencing of patient liver tissues, which aids in understanding and treating fibrotic diseases. Alentis aims to modify and reverse disease progression, ultimately addressing significant health challenges associated with liver-related conditions.
Eyeware
Seed Round in 2019
Eyeware Tech SA, founded in 2016 and based in Martigny, Switzerland, specializes in developing advanced eye and head tracking software, known as GazeSense, which utilizes consumer cameras. This innovative technology is applicable across a variety of sectors, including social robotics, automotive, healthcare, gaming, and advertising. As a research spin-off from EPFL and the Idiap Research Institute, Eyeware focuses on creating platform-independent solutions that leverage proprietary computer vision algorithms and machine perception AI. These advancements enable cost-effective and reliable eye tracking without the need for specialized hardware. Eyeware's software allows devices to understand user attention and intention, facilitating more natural interactions between people and technology. The company’s offerings are designed to support a wide range of applications, positioning Eyeware as a key player in the integration of human perception technology into everyday consumer devices and services.
Amal Therapeutics
Series B in 2018
Amal Therapeutics SA is a biotechnology company based in Geneva, Switzerland, founded in 2012 as a spin-off from the University of Geneva. The company specializes in the research and development of therapeutic vaccines for oncology, utilizing a proprietary cell penetrating peptide platform. Amal Therapeutics focuses on creating peptide-based vaccines that generate cellular immune responses, including the activation of killer T cells that target tumor cells and promote long-lasting immunological memory. This approach aims to enhance the efficacy of cancer treatments and improve outcomes for patients. As of July 2019, Amal Therapeutics operates as a subsidiary of Boehringer Ingelheim GmbH.
Amal Therapeutics
Series B in 2017
Amal Therapeutics SA is a biotechnology company based in Geneva, Switzerland, founded in 2012 as a spin-off from the University of Geneva. The company specializes in the research and development of therapeutic vaccines for oncology, utilizing a proprietary cell penetrating peptide platform. Amal Therapeutics focuses on creating peptide-based vaccines that generate cellular immune responses, including the activation of killer T cells that target tumor cells and promote long-lasting immunological memory. This approach aims to enhance the efficacy of cancer treatments and improve outcomes for patients. As of July 2019, Amal Therapeutics operates as a subsidiary of Boehringer Ingelheim GmbH.
Amal Therapeutics
Series A in 2016
Amal Therapeutics SA is a biotechnology company based in Geneva, Switzerland, founded in 2012 as a spin-off from the University of Geneva. The company specializes in the research and development of therapeutic vaccines for oncology, utilizing a proprietary cell penetrating peptide platform. Amal Therapeutics focuses on creating peptide-based vaccines that generate cellular immune responses, including the activation of killer T cells that target tumor cells and promote long-lasting immunological memory. This approach aims to enhance the efficacy of cancer treatments and improve outcomes for patients. As of July 2019, Amal Therapeutics operates as a subsidiary of Boehringer Ingelheim GmbH.
Outfittery
Series B in 2014
Outfittery provides an online personal shopping service for men. OUTFITTERY’s mission is to take the pain out of shopping for men – as an online version of the “personal shopping”.Their personal style experts put together two or three outfits for each of their customers based on their preferences and personality from a range of top brands. Each customer is served and advised personally after a first online contact and an (optional) phone call. They keep the range of clothes constantly up to date by looking for the most interesting men´s fashion brands and the best items of popular designers worldwide.Their service is free and the individually selected items are sent to their customers free of charge. Customers only pay for the pieces that they want to keep in their wardrobe and feel comfortable in. OUTFITTERY today is the pioneer and market leader in curated shopping for men in Europe, shipping to eight countries (Germany, Austria, Switzerland, Netherlands, Belgium, Luxemburg, Sweden and Denmark).
Snow & Alps
Venture Round in 2014
With Snowbon the company created the first online booking platform, which offers top deals for ski extras in the Alps. Zhanks to the unique Snow Guarantee wintersport enthusiasts can book off-season ski extras totally risk-free: should the ski resort be closed due to lack of snow, the customer will receive his money back. Snowbon offers ski passes, ski lessons and rental equipment as stand alone as well as in attractive packages for winter sports regions in Austria, Germany, France, Italy and Switzerland. If you can't find an offer for you, just sign up for our free newsletter and we will keep you up to date about our best deals!
Inreal Technologies
Venture Round in 2013
Inreal Technologies GmbH is a virtual reality company based in Karlsruhe, Germany, with additional offices in Switzerland and New York. Founded in 2011, the company specializes in providing architecture visualization solutions for the real estate sector. Its technology allows users to experience realistic 3D simulations of planned environments through virtual reality headsets, enabling immersive exploration of prospective buildings before they are constructed. This innovative approach enhances decision-making processes for clients in both residential and commercial real estate, helping them better understand spatial dynamics and design features.
Outfittery
Series A in 2013
Outfittery provides an online personal shopping service for men. OUTFITTERY’s mission is to take the pain out of shopping for men – as an online version of the “personal shopping”.Their personal style experts put together two or three outfits for each of their customers based on their preferences and personality from a range of top brands. Each customer is served and advised personally after a first online contact and an (optional) phone call. They keep the range of clothes constantly up to date by looking for the most interesting men´s fashion brands and the best items of popular designers worldwide.Their service is free and the individually selected items are sent to their customers free of charge. Customers only pay for the pieces that they want to keep in their wardrobe and feel comfortable in. OUTFITTERY today is the pioneer and market leader in curated shopping for men in Europe, shipping to eight countries (Germany, Austria, Switzerland, Netherlands, Belgium, Luxemburg, Sweden and Denmark).
Outfittery
Seed Round in 2012
Outfittery provides an online personal shopping service for men. OUTFITTERY’s mission is to take the pain out of shopping for men – as an online version of the “personal shopping”.Their personal style experts put together two or three outfits for each of their customers based on their preferences and personality from a range of top brands. Each customer is served and advised personally after a first online contact and an (optional) phone call. They keep the range of clothes constantly up to date by looking for the most interesting men´s fashion brands and the best items of popular designers worldwide.Their service is free and the individually selected items are sent to their customers free of charge. Customers only pay for the pieces that they want to keep in their wardrobe and feel comfortable in. OUTFITTERY today is the pioneer and market leader in curated shopping for men in Europe, shipping to eight countries (Germany, Austria, Switzerland, Netherlands, Belgium, Luxemburg, Sweden and Denmark).
Windeln.de
Series B in 2012
windeln.de, together with its subsidiaries, operates as an online retailer of products for babies, toddlers, children, and young mothers in Germany, Austria, Switzerland, the Czech Republic, Spain, and China. It operates through German Shop, International Shops, and Shopping Clubs segments. The company offers a range of products, including diapers, baby food, drugstore products, clothes, toys, strollers, child car seats, baby monitors, and children’s furniture.
Windeln.de
Series A in 2011
windeln.de, together with its subsidiaries, operates as an online retailer of products for babies, toddlers, children, and young mothers in Germany, Austria, Switzerland, the Czech Republic, Spain, and China. It operates through German Shop, International Shops, and Shopping Clubs segments. The company offers a range of products, including diapers, baby food, drugstore products, clothes, toys, strollers, child car seats, baby monitors, and children’s furniture.
SAW Instruments
Series B in 2011
SAW Instruments specializes in the development, manufacture, and distribution of analytical systems designed for the life sciences sector. The company's innovative equipment enables label-free analysis of biomolecular interactions, offering a combination of high sensitivity, stability, and user-friendliness. SAW Instruments' products are utilized by leading research institutions in Germany and Switzerland, reflecting their effectiveness and reliability in advanced scientific research.
Windeln.de
Venture Round in 2010
windeln.de, together with its subsidiaries, operates as an online retailer of products for babies, toddlers, children, and young mothers in Germany, Austria, Switzerland, the Czech Republic, Spain, and China. It operates through German Shop, International Shops, and Shopping Clubs segments. The company offers a range of products, including diapers, baby food, drugstore products, clothes, toys, strollers, child car seats, baby monitors, and children’s furniture.
SAW Instruments
Seed Round in 2010
SAW Instruments specializes in the development, manufacture, and distribution of analytical systems designed for the life sciences sector. The company's innovative equipment enables label-free analysis of biomolecular interactions, offering a combination of high sensitivity, stability, and user-friendliness. SAW Instruments' products are utilized by leading research institutions in Germany and Switzerland, reflecting their effectiveness and reliability in advanced scientific research.
United Maps
Series A in 2009
United Maps strategy is to licence basemaps - from vehicle navigation market leaders like Navteq, Tele Atlas or AND – and algorithmically match them with value-added cartographic data and relevant information layers thereby conflated into new data products. United Maps generates content-rich, white-labeled, highly detailed and fully routable vector maps for mobile and pedestrian usecases. Proprietary conflation algorithms automatically match vectorized basemaps with a high degree of precision. Relevant content layers are added for mobile usecases and seamless multimodal navigation: » public transport (subway, tram, railnetworks) » pathes, walkways and trails for hiking and outdoor » precise house footprints, addresses The hyperlocal mapping products enable location-based applications, media and services for connected mobile devices, BPO, LBS and multi-modal navigation on a mobile, human scale. United Maps operates in B2B and professional services, offering white-labeled and on-demand services. Germany is scheduled for Q1/09, followed by Austria, Switzerland and a rollout of 200 larger European cities.
United Maps
Seed Round in 2008
United Maps strategy is to licence basemaps - from vehicle navigation market leaders like Navteq, Tele Atlas or AND – and algorithmically match them with value-added cartographic data and relevant information layers thereby conflated into new data products. United Maps generates content-rich, white-labeled, highly detailed and fully routable vector maps for mobile and pedestrian usecases. Proprietary conflation algorithms automatically match vectorized basemaps with a high degree of precision. Relevant content layers are added for mobile usecases and seamless multimodal navigation: » public transport (subway, tram, railnetworks) » pathes, walkways and trails for hiking and outdoor » precise house footprints, addresses The hyperlocal mapping products enable location-based applications, media and services for connected mobile devices, BPO, LBS and multi-modal navigation on a mobile, human scale. United Maps operates in B2B and professional services, offering white-labeled and on-demand services. Germany is scheduled for Q1/09, followed by Austria, Switzerland and a rollout of 200 larger European cities.